Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophage-activating factors (MAFs) are a group of molecules, primarily cytokines or receptor-based signals, that prime macrophages to enhance their cytotoxicity against tumors, increase cytokine secretion, and improve clearance of pathogens. A key example is GcMAF (Gc protein-derived Macrophage Activating Factor), which is produced by deglycosylation of vitamin D-binding protein (DBP) and interacts with CLEC10A isoforms to modulate macrophage activity. Other molecules that activate macrophages through different receptors (e.g., TLRs, complement receptors) can be considered functional 'replacements' even though they represent alternative pathways.
Priming macrophages to enhance cytotoxicity, cytokine secretion, and phagocytosis via CLEC10A isoforms and other receptors like TLRs and complement receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage Activating Factor (MAF).